Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4466_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
44 Мб
Скачать
298
https://t.me/medicina_free
B. Bursal Duramaz et al.
In patients 6–18years old:
– If there is no history of PCV13 or PPSV23, one dose of PCV13 and one dose of
PPSV23 after at least 8weeks.
– If there is any PCV13 but no PPSV23, one dose of PPSV23 at least 8weeks after
the last dose of PCV13.
– If PPSV23 is present, but PCV13 is absent, one dose of PCV13 at least 8weeks
after the last dose of PPSV23.
– When both PCV13 and PPSV23 are indicated, administer PCV13 rst. PCV13
and PPSV23 should not be administered during the same visit [6163].
Vaccination with an age-appropriate meningococcal conjugate vaccine (MCV­ACWY) against meningococcal serogroups A, C, W, and Y, and meningococcal B vaccine is recommended for children at high risk for meningococcal disease (e.g., asplenia, and complement, factor D, and factor H deciencies). In MCVs, capsular polysaccharides of N. meningitidis A, C, W, and Y serogroups are conjugated to the diphtheria toxin mutant CRM197 (ACWY-CRM), the tetanus toxoid (ACWY-TT), and the diphtheria toxin (ACWY-D). The minimum age is 2 months for MCV­ACWY- CRM and MCV-ACWY-TT and 9 months for MCV-ACWY-D [63].
Serogroup B meningococcal vaccines have also been approved in children (≥2 months old) at high risk for meningococcal disease. Adolescents and other risk groups should also be vaccinated to reduce nasopharyngeal colonization and pro­vide immunity [64].
22.9 Conclusion
Recurrent meningitis in children is a rare but life-threatening phenomenon and increases the likelihood of repeated hospitalization of the child, with multiple and invasive risks. A detailed history and physical examination should form the basis of the evaluation. The patient should be questioned in detail about hearing impair­ment, speech delay, head trauma, rhino/ear discharge, recurrent infections, and family history of immunodeciency. Physical examination should be done very carefully to evaluate for head and midline abnormalities. It generally poses a diag­nostic challenge. An organized approach and early diagnosis of any underlying abnormality are essential and may be vital to preventing further attacks and improv­ing the outcome for the affected patient. Vaccination of patients also plays a crucial role in preventing recurrence.
References
1. Tebruegge M, Curtis N.Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bac­terial meningitis. Clin Microbiol Rev. 2008;21:519–37.
2. Livingston RA, Harrison CJ. Recurrent meningitis. In: Long SS, Prober CG, Fischer M, Kimberlin DW, editors. Principles and practice of pediatric infectious diseases. 6th ed. Philadelphia: Elsevier; 2023. p.305–10.
22 Recurrent Meningitis, Congenital Defects, andHearing Loss
https://t.me/medicina_free
3. Gao B, Yang J, Zhuang S, etal. Mollaret meningitis associated with an intraspinal epidermoid cyst. Pediatrics. 2007;120:220–4.
4. Kriss TC, Kriss VM, Warf BC.Recurrent meningitis: the search for the dermoid or epidermoid tumor. Pediatr Infect Dis J. 1995;14:697–700.
5. Quartier P, Foray S, Casanova J, etal. Enteroviral meningoencephalitis in X-linked agamma­globulinemia: intensive immunoglobulin therapy and sequential viral detection in cerebrospi­nal uid by polymerase chain reaction. Pediatr Infect Dis J. 2000;19:1106–8.
6. Lunardi P, Missori P, Fraioli B.Chemical meningitis: unusual presentation of a cerebellar astrocytoma: case report and review of the literature. Neurosurgery. 1989;25:264–70.
7. Uchida Y, Matsubara K, Wada T, etal. Recurrent bacterial meningitis by three different patho­gens in an isolated asplenic child. J Infect Chemother. 2012;18:576–80.
8. Driel V, Bekker V, Spanjaard L, van der Ende A, Kuijpers TW. Epidemiologic and micro­biologic characteristics of recurrent bacterial and fungal meningitis in the Netherlands, 1988-2005. Clin Infect Dis. 2008;47:42–51.
9. Adriani KS, van de Beek D, Brouwer MC, Spanjaard L, Gans J.Community-acquired recur­rent bacterial meningitis in adults. Clin Infect Dis. 2007;45:46–51.
10. Brouwer MC, Tunkel AR, van de Beek D.Epidemiology, diagnosis, and antimicrobial treat­ment of acute bacterial meningitis. Clin Microbiol Rev. 2011;23:467–92.
11. Black J, Hickson L, Black B, Khan A.Paediatric cochlear implantation: adverse prognostic factors and trends from a review of 174 cases. Cochlear Implants Int. 2014;15:62–77.
12. Biswas S, Millward CP, Riordan A, Sinha A, Avula S.Craniopharyngeal duct: a cause of recur­rent meningitis. BJR Case Rep. 2015;1(3):20150022.
13. Cantatore S, Crisa A, Guaraldi N, Pancaldi ME, Iughetti L.Recurrent pneumococcal men­ingitis in a child with transethmoidal encephalocele: a case report and review of literature. Minerva Pediatr. 2011;63:119–24.
14. Jain A, Tullu MS, Agrawal M, Jadhav DU.Occult encephalocele causing recurrent meningitis. Pediatr Neurol. 2015;53:270–1.
15. Muzzi E, Battelino S, Gregori M, Pellegrin A, Orzan E.Life-threatening unilateral hearing impairments. Review of the literature on the association between inner ear malformations and meningitis. Int J Pediatr Otorhinolaryngol. 2015;79:1969–74.
16. Lee E, Lee EH, Yum MS, Ko TS.Recurrent bacterial meningitis in pediatric patients with anatomical defects. J Korean Child Neurol Soc. 2011;19:102–8.
17. Fishman AJ. Imaging and anatomy for cochlear implants. Otolaryngol Clin N Am. 2012;45:1–24.
18. Glueckert R, Rask-Andersen H, Sergi C, etal. Histology and synchrotron radiation-based microtomography of the inner ear in a molecularly conrmed case of CHARGE syndrome. Am J Med Genet A. 2010;152:665–73.
19. Goddard JC, Meyer T, Nguyen S, Lambert PR.New considerations in the cause of spontane­ous cerebrospinal uid otorrhea. Otol Neurotol. 2010;31:940–5.
20. Anandi S, Tullu MS, Bhatia S, Agrawal M.Mondini dysplasia as a cause for recurrent bacterial meningitis: an early diagnosis. J Child Neurol. 2012;27:1052–5.
21. Kohrmann M, Schellinger PD, Wetter A, Hahnel S.Nasal meningoencephalocele, an unusual cause for recurrent meningitis: case report and review of the literature. J Neurol. 2007;254:259–60.
22. Lucas MJ, Brouwer MC, van de Beek D.Neurological sequelae of bacterial meningitis. J Infect. 2016;73:18–27.
23. Masri A, Alassaf A, Khuri-Bulos N, Zaq I, Hadidy A, Bakri FG.Recurrent meningitis in chil­dren: etiologies, outcome, and lessons to learn. Childs Nerv Syst. 2018;34:1541–7.
24. Mook-Kanamori BB, Geldhoff M, van der Poll T, van de Beek D.Pathogenesis and patho­physiology of pneumococcal meningitis. Clin Microbiol Rev. 2011;24:557–91.
25. Kutz JW, Simon LM, Chennupati SK, Giannoni CM, Manolidis S. Clinical predictors for hearing loss in children with bacterial meningitis. Arch Otolaryngol Head Neck Surg. 2006;132:941–5.
26. Arditi M, Mason EO Jr, Bradley JS, etal. Three-year multicenter surveillance of pneumococ­cal meningitis in children: clinical characteristics, and outcome related to penicillin suscepti­bility and dexamethasone use. Pediatrics. 1998;102:1087–97.
299
300
https://t.me/medicina_free
27. Panuganti SK, Nadal S.Acute bacterial meningitis beyond the neonatal period. In: Long SS, Prober CG, Fischer M, Kimberlin DW, editors. Principles and practice of pediatric infectious diseases. 6th ed. Philadelphia: Elsevier; 2023. p.286–97.
28. Koomen I, Grobbee DE, Roord JJ, Donders R, Jennekens-Schinkel A, van Furth AM.Hearing loss at school age in survivors of bacterial meningitis: assessment, incidence, and prediction. Pediatrics. 2003;112:1049–53.
29. Roine I, Pelkonen T, Cruzeiro ML, Kataja M, Peltola H, Pitkaranta A.Hearing impairment and its predictors in childhood bacterial meningitis in Angola. Pediatr Infect Dis J. 2013;32:563–5.
30. Edmond K, Clark A, Korczak VS, Sanderson C, Grifths UK, Rudan I.Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:317–28.
31. Durisin M, Bartling S, Arnoldner C, et al. Cochlear osteoneogenesis after meningitis in cochlear implant patients: a retrospective analysis. Otol Neurotol. 2010;31:1072–8.
32. Lieu JE, Tye-Murray N, Fu Q. Longitudinal study of children with unilateral hearing loss. Laryngoscope. 2012;122:2088–95.
33. Masuda S, Usui S, Matsunaga T. High prevalence of inner-ear and/or internal auditory canal malformations in children with unilateral sensorineural hearing loss. Int J Pediatr Otorhinolaryngol. 2013;77:228–32.
34. Carrol ED, Latif AH, Misbah SA.Recurrent bacterial meningitis: the need for sensitive imag­ing. BMJ. 2001;323:501–3.
35. Joshi VM, Navlekar SK, Kishore GR, Reddy KJ, Kumar VEC.CT and MR imaging of the inner ear and brain in children with congenital sensorineural hearing loss. Radiographics. 2012;32:683–98.
36. Park AH, Kou B, Hotaling A, Azar-Kia B, Leonetti J, Papsin B.Clinical course of pediatric congenital inner ear malformations. Laryngoscope. 2000;110:1715–9.
37. Stein LK, Jabaley T, Spitz R, Stoakley D, McGee T.The hearing-impaired infant: patterns of identication and habilitation revisited. Ear Hear. 1990;11:201–5.
38. Bachmann-Harildstad G. Diagnostic values of beta-2 transferrin and beta-trace protein as markers for cerebrospinal uid stula. Rhinology. 2008;46:82–5.
39. Ziu M, Savage JG, Jimenez DF. Diagnosis and treatment of cerebrospinal uid rhinorrhea following accidental traumatic anterior skull base fractures. Neurosurg Focus. 2012;32:e3.
40. Chan DT, Poon WS, Ip CP, Chiu PW, Goh KY.How useful is glucose detection in diagnosing cerebrospinal uid leak? The rational use of CT and beta-2 transferrin assay in detection of cerebrospinal uid stula. Asian J Surg. 2004;27:39–42.
41. Stone JA, Castillo M, Neelon B, Mukherji SK.Evaluation of CSF leaks: high-resolution CT compared with contrast-enhanced CT and radionuclide cisternography. AJNR Am J Neuroradiol. 1999;20:706–12.
42. Lloyd MN, Kimber PM, Burrows EH.Posttraumatic cerebrospinal uid rhinorrhoea: modern high-denition computed tomography is all that is required for the effective demonstration of the site of leakage. Clin Radiol. 1994;49:100–3.
43. LaFata V, McLean N, Wise SK, DelGaudio JM, Hudgins PA.CSF leaks: correlation of high­resolution CT and multiplanar reformations with intraoperative endoscopic ndings. AJNR Am J Neuroradiol. 2008;29:536–41.
44. Mostafa BE, Khafagi A.Combined HRCT and MRI in the detection of CSF rhinorrhea. Skull Base. 2004;14:157–62.
45. Zapalac JS, Marple BF, Schwade ND.Skull base cerebrospinal uid stulas: a comprehensive diagnostic algorithm. Otolaryngol Head Neck Surg. 2002;126:669–76.
46. Tuntiyatorn L, Laothammatas J.Evaluation of MR cisternography in diagnosis of cerebrospi­nal uid stula. J Med Assoc Thail. 2004;87:1471–6.
47. Presutti L, Mattioli F, Villari D, Marchioni D, Alicandri-Ciufelli M.Transnasal endoscopic treatment of cerebrospinal uid leak: 17 years’ experience. Acta Otorhinolaryngol Ital. 2009;29:191–6.
B. Bursal Duramaz et al.
22 Recurrent Meningitis, Congenital Defects, andHearing Loss
https://t.me/medicina_free
48. Kasiakou SK, Rafailidis PI, Liapropoulos K, Falagas ME. Cure of posttraumatic recur­rent multiresistant gram-negative rod meningitis with intraventricular colistin. J Infect. 2005;50:348–52.
49. Verma RK, Tripathi N, Panda NK.Recurrent pyogenic meningitis and Mondini dysplasia: surgeons nightmare-our experience. Int J Pediatr Otorhinolaryngol Extra. 2012;7:175–8.
50. Wilson MN, Simon LM, Arriaga MA, Nuss DW, Lin JA. The management of spontaneous otogenic CSF leaks: a presentation of cases and review of literature. J Neurol Surg B Skull Base. 2014;75:117–24.
51. Ozcan C, Vayisoglu Y, Gorur K, Yildiz A, İsmi O, Kuyucu N.Mondini dysplasia presenting with recurrent meningitis. J Int Adv Otol. 2010;6:415–8.
52. Isaak AM, Faig AB, Martínez S, et al. Recurrent meningitis due to anatomical defects: the bacteria indicates its origin. An Pediatr (Barc). 2015;82:388–396 [article in Spanish, abstract in English].
53. Rupa V, Agarwal I, Rajshekhar V. Congenital perilymph stula causing recurrent men­ingitis: lessons learnt from a single-institution case series. Otolaryngol Head Neck Surg. 2014;150:285–91.
54. Gonzalez JR, Mattingly JK, Cass SP.Stapes footplate deformity leading to perilymphatic s­tula and recurrent meningitis. Int J Pediatr Otorhinolaryngol Extra. 2017;17:31–5.
55. Kamogashira T, Akamatsu Y, Kashio A, etal. Development of auditory skills after cochlear implantation in children with inner ear malformations. Acta Otolaryngol. 2016;136:78–82.
56. Tunkel AR, Hasbun R, Bhimraj A, etal. 2017 Infectious Diseases Society of America’s clini­cal practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis. 2017;64:34–65.
57. Friedman JA, Ebersold MJ, Quast LM.Posttraumatic cerebrospinal uid leakage. World J Surg. 2001;25:1062–6.
58. Eftekhar B, Ghodsi M, Nejat F, Ketabchi E, Esmaeeli B.Prophylactic administration of cef­triaxone for the prevention of meningitis after traumatic pneumocephalus: results of a clinical trial. J Neurosurg. 2004;101:757–61.
59. Ratilal B, Costa J, Sampaio C.Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures. Cochrane Database Syst Rev. 2006:CD004884.
60. Baltas I, Tsoulfa S, Sakellariou P, Vogas V, Fylaktakis M, Kondodimou A.Posttraumatic men­ingitis: bacteriology, hydrocephalus, and outcome. Neurosurgery. 1994;35:422–6.
61. Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012;61:816–9.
62. Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vac­cine and 23-valent pneumococcal polysaccharide vaccine among children aged 6–18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2013;62:521–4.
63. Centers for Disease Control and Prevention. Recommended child and adolescent immuniza­tion schedule for ages 18 years and younger—United States 2022. CDC; 2022. https://www.
cdc.gov/vaccines/schedules/downloads/child/0- 18yrs- child- combined- schedule.pdf. Accessed
22 Dec 2022.
64. Kaaijk P, van der Ende A, Luytjes W.Routine vaccination against MenB: considerations for implementation. Hum Vaccin Immunother. 2013;10:310–6.
301
Focal Suppurative Infections
https://t.me/medicina_free
oftheCentral Nervous System
23
inChildren andHearing Loss
TaylanÇelik, MustafaHacımustafaoğlu, andDennisChua
23.1 Introduction
Cerebral sinus thrombosis (CST) is a severe cerebrovascular disease that can cause adverse outcomes such as hearing loss (HL), although it is rare in children. Today, it is being diagnosed more frequently due to the widespread use of neuroimaging, more prolonged survival of children with a tendency to thrombosis, and increased clinical awareness. It should be kept in mind when symptoms (after exclusion of acute bacterial meningitis) such as unresponsive to treatment or headache and vom­iting develop in infections such as recurrent and/or complicated acute bacterial rhi­nosinusitis, otitis media, and mastoiditis, especially in children with a tendency to thrombosis. In such patients, it is important to evaluate the brain imaging for CST in order not to miss the diagnosis.
T. Çelik (*) Division of Pediatric Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, Türkiye e-mail: taylanchelik@gmail.com
M. Hacımustafaoğlu Division of Pediatric Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Uludağ University, Bursa, Türkiye e-mail: mkemal@uludag.edu.tr
D. Chua Section of Otorhinolaryngology, ENT Surgeons Medical Centre, Mount Elizabeth Hospital, Singapore, Singapore e-mail: dennis.chua.yk@gmail.com
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 A. E. Arısoy et al. (eds.), Hearing Loss in Congenital, Neonatal and Childhood Infections, Comprehensive ENT, https://doi.org/10.1007/978-3-031-38495-0_23
303
304
https://t.me/medicina_free
T. Çelik et al.
23.2 Septic Dural Sinus Thrombosis
23.2.1 Dural Venous Sinuses: Dural Sinus, Cerebral Sinus,
andCranial Sinus
The dural venous sinuses, the main venous drainage systems of the central nervous system (CNS), are the venous channels located in the cranium, on the inner surface of the bone, and between the endosteal and meningeal layers of the dura mater [1]. The cerebral venous system consists mainly of a network of supercial cortical, medullary, and deep cerebral veins that drain into the dural sinuses [2]. Cerebral venous return generally drains into the nearest venous sinuses, followed by drainage into the internal jugular vein through the transverse (lateral) and sigmoid sinuses (Figs.23.1 and 23.2). In addition, they provide normal physiological drainage of cerebrospinal uid (CSF), such as absorption and discharge into the dural sinuses through arachnoid villi that penetrate the dura from the subarachnoid area and reach the dural sinuses (Fig.23.3).
Central nervous system venous circulation shows some differences from venous circulation in other body systems; veins usually do not run parallel to the arteries, cerebral veins are very thin due to the absence of muscular layers, and they do not have venous valves. In addition, there is an extensive collateral system in the corti­cal, deep veins, and sinuses, which contributes to the continuation of venous drain­age by alternative routes when the primary pathway is disabled. There may also be signicant individual differences in the cerebral venous drainage system. Therefore, it is helpful to consider these factors in the clinical and radiological evaluation of a patient with septic venous sinus thrombosis.
6
Fig. 23.1 Brain major dural sinus systems. (Courtesy Taylan Çelik, MD)
1
2 3
7
8
54
9
1- Supeior sagittal sinus
2- Inferior sagittal sinus
3- Right transverse sinus
4- Left ophthalmic vein
5- Left cavernous sinus
6- Inter-cavernous sinus
7- Right sigmoid sinus
8- Left ınternal juguler ven
9- Left ear
Emissary veins
Transverse sinus
Sigmoid sinus
Internal Juguler vein Internal Juguler vein
l
23 Focal Suppurative Infections of the Central Nervous System in Children…
https://t.me/medicina_free
Superior sagittal sinus Inferior sagittal sinus
Confluence of sinuses Transverse sinus
305
Petrosal sinus
Ophhalmic vein Sigmoid sinus
Cavernous sinus Petrosal sinus
Fig. 23.2 Cerebral venous ow chart
Superior sagial sinus
Emissary vein
Cerebral vein
Dura mater
Aracnoid mater
Pia mater
Diploic vein
Arachnoid granulaon vil
Bone
Subarachnoid space
Cerebral cortex
Fig. 23.3 Schematic view of the arachnoid membrane, arachnoid granulation, dura mater, and cerebral venous sinus relationship in the brain; arachnoid granulations originating from the arach­noid membrane reach the venous sinuses pass the dura from appropriate places and provide cere­brospinal uid drainage. (Courtesy Taylan Çelik, MD)
23.2.2 Cerebral Sinus Thrombosis
Cerebral sinus thrombosis describes a set of disorders that include thrombosis of the cerebral venous system; it can be septic or aseptic. In Europe and North America, the incidence is estimated at 0.6 per 100,000 per year in childhood, with male
306
https://t.me/medicina_free
predominance (60–70%) and neonates accounting for 30–50% of the cases [1, 2]. Cerebral sinus thrombosis can be divided into three main sections: cavernous sinus thrombosis (CavST), lateral (transverse) sinus thrombosis (LST), and superior sag­ittal sinus thrombosis (very rare).
This chapter will give general information about the cerebral dural sinuses (cav­ernous, lateral, and sagittal) and their thromboses, followed by the clinical, labora­tory, and treatment approaches of septic CST, especially in children, and its evaluations in terms of hearing loss.
T. Çelik et al.
23.2.2.1 Risk Factors
In general, CST occurs in previously healthy children, most commonly in the pres­ence of or after mastoiditis (characterized by postauricular pain, swelling, erythema, or tenderness) and head/neck infections such as sinusitis, dehydration, and iron de­ciency anemia. Other risk factors predisposing children to CST are inammatory bowel disease, congenital heart diseases, cancer, autoimmune disorders, chronic kidney disease, nephrotic syndrome, systemic lupus erythematosus, and other chronic diseases [2, 3]. Local stasis that may occur in cerebral blood ow and condi­tions that may cause it (such as head trauma, CNS tumors, and intracranial surgery) may predispose to CST and/or aggravate the existing CST condition [3]. In addi­tion, hereditary causes of thrombophilia such as antithrombin deciency, protein C and protein S deciency, factor V Leiden mutation, and homocysteinemia resulting from methylenetetrahydrofolate reductase (MTHFR) gene mutation are prothrom­botic genetic conditions. Acquired nephrotic syndrome and antiphospholipid anti­bodies are other causes that may be risk factors in etiology, which tend to cause thrombosis in general, and are also the risk factors for CST, although not detected in every patient. Approximately 10–20% of children with CST may develop a recur­rent thrombotic venous event in the future, of which at least half develop as sys­temic rather than cerebral venous thrombosis [3].
23.2.2.2 Pathophysiology
There is no valve mechanism in the cerebral veins and sinuses. Thrombosis in the venous system causes outow obstruction, congestion, subsequent capillary hydro­static pressure increase, uid leakage into the interstitium, and edema. The increase in hydrostatic capillary pressure above a certain level and the presence of edema may lead to a decrease in arterial blood ow/supply and local ischemia in the brain tissue and subsequently to neurological ndings. These physiopathological and clinical ndings may cause different clinical ndings to be more pronounced in dif­ferent regions, depending on neighboring structures [3]. When these physiopatho­logical changes affect the cochlear system, it may cause hypoxia due to insufciency of venous circulation in the cochlear system, and then, sensorineural HL (SNHL) may develop. Sensorineural HL (unilateral or bilateral) may arise as thrombosis reaches the cochlear or labyrinthine veins [4].
23 Focal Suppurative Infections of the Central Nervous System in Children…
https://t.me/medicina_free
307
23.2.2.3 Clinical Findings
In CST, since thrombosis causes cerebral ischemia, the most common complaints that bring the patient to the clinician are severe headache, vomiting, and confusion that progresses over days. In addition, some different complaints according to the anatomical region may develop [1, 2]. For example, in CavST, proptosis, chemosis, oculomotor nerve (cranial nerve [CN]-III), trochlear nerve (CN-IV), trigeminal nerve (CN-V), and abducens nerve (CN-VI), involvement ndings and LST, otitis signs, unilateral CN-V, and CN-VI ndings may develop. However, since the cere­bral venous sinuses are interconnected, and there is no valve mechanism in the sinuses, some similar clinical ndings can be shared in common. Mental status changes vary in patients; sometimes, only irritability and sleepiness may occur, or progression to stupor and coma may be seen [2]. In septic CST, in addition to the neurological ndings secondary to thrombosis, ndings of adjacent region infection such as sinusitis, persistent and/or inadequately treated acute otitis media (AOM), and mastoiditis also accompany the clinical picture. Hearing loss in septic CST may be of the sensorineural type due to the underlying chronic/persistent otitis (conduc­tive type) or acute cochlear dysfunction, and the CN-VII is affected [57]. Most (about 95%) of these are unilateral. Acute HL is dened as HL that develops sud­denly within days [5, 8].
23.2.3 Septic Cerebral Sinus Thrombosis
Septic CST is not common. In addition, widespread symptoms and signs, which can also be seen in other diseases, may lead to misinterpretation of clinical signs [1]. Therefore, overlooked cases may lead to an underestimation of the incidence. In this respect, it is benecial for the physician to interpret the clinical ndings and physi­cal examination rationally.
Septic CST may show some differences according to the regions where it is involved. Here, the most common septic CavST, septic LST, and septic sagittal sinus thrombosis will be discussed briey.
23.3 Septic Cavernous Sinus Thrombosis
23.3.1 Anatomy
The cavernous sinuses are located just lateral to the base of the sella turcica and the sphenoid paranasal sinuses. They are nearly located at the center of the dural sinuses. These irregularly shaped sinuses have multiple trabeculae that act as strainers to trap bacteria; this feature explains why cavernous sinuses have a higher risk of infection than other dural sinuses. The cavernous sinuses are connected by the sella turcica and two intercavernous sinuses that run in front and behind the pituitary gland and sella turcica (Figs.23.1 and 23.4). Therefore, especially if treatment is
308
https://t.me/medicina_free
T. Çelik et al.
1
2
3
4
5
6
7
Fig. 23.4 Cavernous sinus anatomy and adjacent structures (coronal section). (Courtesy Taylan Çelik, MD)
98
1. Oculomotor nerve (Ⅲ)
2. Trochlear nerve (Ⅳ)
3. Ophtalmic nerve (
4. Maxillary nerve (
5. Abducens nerve (Ⅵ)
6. Internal carotid arter
7. Sphenoidal sinus
8. Sella turcica
9. Cavernous sinus
2
)
1
)
delayed, the event may spread to the other side via venous connections; then, bilat­eral infection may develop, and clinical ndings may be bilateral [1].
Some cranial nerves, including CN-III, CN-IV, ophthalmic (CNV1), and maxil­lary branches (V2) of CNV, can be counted and are located lateral to the cavernous sinuses. The cranial nerve VI is located more medially in the cavernous sinus and adjacent to the cavernous segment of the internal carotid artery (ICA) (Fig.23.3) [1]. In CavST, in addition to the general symptoms, there may be varying degrees of involvement of these nerves, and narrowing of the ICA may be detected in radio­logical images. Septic CavST is more common in sphenoid sinusitis due to its prox­imity to the sphenoid sinus (Fig.23.4). In addition, in facial infections, especially around the nose (danger triangle), the venous circulation primarily drains into the cavernous and other venous sinuses may increase the risk (Fig.23.5).
23.3.2 Microbiology
The organisms associated with septic CavST differ by the site of primary infection [1, 9]; Staphylococcus aureus accounts for 70% of all infections and is usually asso- ciated with facial infection or sphenoid sinusitis. Community-acquired methicillin­resistant S. aureus (MRSA) has been reported with increasing frequency. Streptococci (including Streptococcus pneumoniae, Streptococcus milleri, and viri- dans group streptococci) are less common. However, in some studies, the most com­mon (60%) microorganism was reported to be Streptococcus anginosus [9]. Anaerobes, Bacteroides spp., and Fusobacterium spp. are less common and are primarily associated with concomitant sinus, tooth, or tonsil infections. Fungal agents such as Rhizopus spp. and other mucormycosis agents, Aspergillus spp. and Schizophyllum, are rarely reported.